Comparison of the Efficacy and Safety of Zotarolimus-, Sirolimus-, and Paclitaxel-Eluting Stents in Patients With ST-Elevation Myocardial Infarction

This publication has 29 references indexed in Scilit:

• Drug-Eluting Versus Bare-Metal Stents in the Treatment of Patients With ST-Segment Elevation Myocardial Infarction
  JACC: Cardiovascular Interventions, 2008
• Four-Year Clinical Follow-Up After Implantation of the Endeavor Zotarolimus-Eluting Stent: ENDEAVOR I, the First-in-Human Study
  The American Journal of Cardiology, 2007
• Zotarolimus-Eluting Stents in Patients with Native Coronary Artery Disease: Clinical and Angiographic Outcomes in 1,317 Patients
  The American Journal of Cardiology, 2007
• The Significance of Preclinical Evaluation of Sirolimus-, Paclitaxel-, and Zotarolimus-Eluting Stents
  The American Journal of Cardiology, 2007
• Meta-analysis of clinical trials on use of drug-eluting stents for treatment of acute myocardial infarction
  American Heart Journal, 2007
• Randomized Trial of Sirolimus-Eluting Stent Versus Bare-Metal Stent in Acute Myocardial Infarction (SESAMI)
  Journal of the American College of Cardiology, 2007
• Overview of Pharmacology and Clinical Trials Program with the Zotarolimus‐Eluting Endeavor Stent
  Journal of Interventional Cardiology, 2006
• Safety and Long-Term Efficacy of Sirolimus Eluting Stent in ST-elevation Acute Myocardial Infarction: The REAL (Registro REgionale AngiopLastiche Emilia-Romagna) Registry
  Cardiovascular Drugs and Therapy, 2006
• Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery
  New England Journal of Medicine, 2003
• Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials
  Published by Elsevier ,2003